Options
Emerging Drug Therapies for Inherited Retinal Dystrophies
Author(s)
Date Issued
2019-12-29
Date Available
2020-09-22T14:18:45Z
Abstract
Worldwide, 1 in 2000 people suffer from inherited retinal dystrophies (IRD). Individuals with IRD typically present with progressive vision loss that ultimately results in blindness. Unfortunately, effective treatment options are not widely available due to the genetic and clinical heterogeneity of these diseases. There are multiple gene, cell, and drug-based therapies in various phases of clinical trials for IRD. This mini-review documents current progress made in drug-based clinical trials for treating IRD.
Type of Material
Conference Publication
Publisher
Springer
Series
Advances in Experimental Medicine and Biology
1185
Copyright (Published Version)
2019 Springer
Language
English
Status of Item
Peer reviewed
Journal
Bowes Rickman C., Grimm C., Anderson R., Ash J., LaVail M., Hollyfield J. (eds.). Retinal Degenerative Diseases
ISBN
978-3-030-27377-4
This item is made available under a Creative Commons License
File(s)
No Thumbnail Available
Name
XX.Sundaramurthi.docx
Size
94.57 KB
Format
Microsoft Word
Checksum (MD5)
68d0cbd86a093730f984bd828fca0ed4